Thoroughbred Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-680
| Closed | -$431K | – | 676 |
|
|
2025
Q1 | $431K | Buy |
680
+88
| +15% | +$55.8K | 0.03% | 455 |
|
|
2024
Q4 | $421K | Buy |
592
+102
| +21% | +$72.5K | 0.03% | 451 |
|
|
2024
Q3 | $515K | Hold |
490
| – | – | 0.03% | 387 |
|
|
2024
Q2 | $515K | Buy |
+490
| New | +$515K | 0.03% | 379 |
|
|
2024
Q1 | – | Sell |
-498
| Closed | -$437K | – | 573 |
|
|
2023
Q4 | $437K | Sell |
498
-6
| -1% | -$5.27K | 0.04% | 390 |
|
|
2023
Q3 | $414K | Buy |
+504
| New | +$414K | 0.04% | 359 |
|